Alnylam Pharmaceuticals
ALNY
#854
Rank
A$42.53 B
Marketcap
A$317.86
Share price
0.23%
Change (1 day)
-51.56%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company